Product Information
DOXYCYCLINE IR-DR 40 MG CAP is a generic product labeled by Mayne Pharma, priced at $4.6707 per EA under NDC 68308066830. Its NADAC has been published 178 times since May 10, 2023.
FDA first approved this application on May 26, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Mayne PharmaNDC
68308066830
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYCYCLINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA050805FDA Approved
5/26/2006
TE Code
AB
On Market Since
2/27/2023
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE IR-DR 40 MG CAP has been published 178 times since May 10, 2023, and over the history we have for it it has declined 66.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.6707 per EA |
|---|---|
| All-time high | $22.5521 (Sep 11, 2024) |
| All-time low | $4.2949 (Aug 19, 2026) |
| 52-week high | $11.3939 |
| 52-week low | $4.2949 |
| Median price | $15.4072 |
| Average price | $14.8902 |
| Largest weekly change | +38.9% (Aug 23, 2023) |
| Weeks tracked | 178 |
| Tracking since | May 10, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mayne Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DOXYCYCLINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXYCYCLINE IR-DR 40 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE IR-DR 40 MG CAP, manufactured by Mayne Pharma, is $4.6707 per EA (NDC 68308066830), effective Sep 30, 2026.
How has the price of DOXYCYCLINE IR-DR 40 MG CAP changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE IR-DR 40 MG CAP has declined 66.7%. It has been tracked across 178 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE IR-DR 40 MG CAP?
Since May 10, 2023, the NADAC for DOXYCYCLINE IR-DR 40 MG CAP has ranged from a low of $4.2949 (Aug 19, 2026) to a high of $22.5521 (Sep 11, 2024), with a median of $15.4072 per EA.
Are there cheaper alternatives to DOXYCYCLINE IR-DR 40 MG CAP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOXYCYCLINE IR-DR 40 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DOXYCYCLINE IR-DR 40 MG CAP?
DOXYCYCLINE IR-DR 40 MG CAP (NDC 68308066830) is labeled by Mayne Pharma, and CMS classifies it as a generic product.